[Is rapid and specific virological detection of influenza really necessary?]

[EDP-938, a new antiviral with inhibitory activity against the nucleoprotein of the respiratory syncytial virus].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022

[Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022

[The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022

PI3K-AKT, JAK2-STAT3 pathways and cell-cell contact regulate maspin subcellular localization.

Cell communication and signaling : CCS·2021

[Clinico-epidemiological characteristics of acute respiratory infections caused by coronavirus OC43, NL63 and 229E].

Revista clinica espanola·2021

[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2021

New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Enfermedades infecciosas y microbiologia clinica·2025

Current situation in the development of a preventive HIV vaccine.

Enfermedades infecciosas y microbiologia clinica·2024

[Use of ribavirin in viruses other than hepatitis C. A review of the evidence].

Enfermedades infecciosas y microbiologia clinica·2024

[Respiratory viruses: old and new. Review of diagnostic methods].

Enfermedades infecciosas y microbiologia clinica·2024

Update on bacterial pathogens: virulence and resistance.

Enfermedades infecciosas y microbiologia clinica·2024

Lifting COVID-19 mitigation measures in Spain (May-June 2020).

Enfermedades infecciosas y microbiologia clinica·2023

ATG13 Promotes K63-Linked Polyubiquitination of MAVS via ASB1 to Restrict Influenza A Virus Replication.

Emerging microbes & infections·2026

Efficacy and safety of sintilimab-based neoadjuvant regimens in patients with resectable gastric or gastroesophageal junction adenocarcinoma: a single-arm systematic review and meta-analysis.

Journal of gastrointestinal oncology·2026

Red blood cell-directed immune responses in COVID-19: Mechanisms, clinical evidence and implications for transfusion medicine.

Transfusion medicine (Oxford, England)·2026

Effect of immune checkpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in locally advanced gastric cancer: study protocol of a single-center, randomised clinical trial.

Contemporary clinical trials·2026

Immune Biomarker Profiling Across Clinical States and Development of a SOFA-Integrated Model for 28-Day Mortality Prediction in Sepsis: A Prospective Cohort Study.

Infection and drug resistance·2026

Severe Nonhepatic Hyperammonemia Associated With Ureaplasma parvum and Mycoplasma hominis Infection in a Dually Immunosuppressed Woman Presenting As Suspected Peritoneal Carcinomatosis.

Cureus·2026

Related Experiment Videos

[Is rapid and specific virological detection of influenza really necessary?]

Related Concept Videos

[EDP-938, a new antiviral with inhibitory activity against the nucleoprotein of the respiratory syncytial virus].

[Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination].

[The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued].

PI3K-AKT, JAK2-STAT3 pathways and cell-cell contact regulate maspin subcellular localization.

[Clinico-epidemiological characteristics of acute respiratory infections caused by coronavirus OC43, NL63 and 229E].

[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2].

New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Current situation in the development of a preventive HIV vaccine.

[Use of ribavirin in viruses other than hepatitis C. A review of the evidence].

[Respiratory viruses: old and new. Review of diagnostic methods].

Update on bacterial pathogens: virulence and resistance.

Lifting COVID-19 mitigation measures in Spain (May-June 2020).

ATG13 Promotes K63-Linked Polyubiquitination of MAVS via ASB1 to Restrict Influenza A Virus Replication.

Efficacy and safety of sintilimab-based neoadjuvant regimens in patients with resectable gastric or gastroesophageal junction adenocarcinoma: a single-arm systematic review and meta-analysis.

Red blood cell-directed immune responses in COVID-19: Mechanisms, clinical evidence and implications for transfusion medicine.

Effect of immune checkpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in locally advanced gastric cancer: study protocol of a single-center, randomised clinical trial.

Immune Biomarker Profiling Across Clinical States and Development of a SOFA-Integrated Model for 28-Day Mortality Prediction in Sepsis: A Prospective Cohort Study.

Severe Nonhepatic Hyperammonemia Associated With Ureaplasma parvum and Mycoplasma hominis Infection in a Dually Immunosuppressed Woman Presenting As Suspected Peritoneal Carcinomatosis.

Related Experiment Videos

[Is rapid and specific virological detection of influenza really necessary?]

Related Concept Videos

Related Articles